SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jonathan Rothschild who wrote (115)6/2/1997 10:43:00 AM
From: Peter H. Proctor   of 670
 
BTW, I've got to be a little careful here, because of patent considerations. What it amounts to is that this whole class of drugs are antiinflammatory agents, as well as being useful in degenerative diseases. So, a new one will be discovered and tried on some animal model for ( say ) arthritis. ( with me, it was diabetic cataract ).

Serendipitously, the researchers will notice some effect on hair loss/growth. So, this keeps getting rediscovered. Uniquely, Procyte happens to have taken one of them to the FDA-approval stage. Sure Procytes stuff works--- 'most all these agents seem to work, at least a little. BTW, this market is small enough that I would be surprised if Procyte gets competition in it, even tho there are other agents.

BTW, if you want a review on this whole area and its implications, read ( he says modestly ) P. Proctor, Free Radicals and Human Disease, CRC Handbook of Free Radicals and Antioxidants, vol 1, p209. Procytes stuff is probably effective against a lot more stuff than surgery-induced hair loss, etc. if they can ever get the funding. Stuff like altzheimers, stroke, etc.

Dr. P
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext